These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 25128064)

  • 1. Designing a recombinant chimeric construct contain MUC1 and HER2 extracellular domain for prediagnostic breast cancer.
    Gheybi E; Amani J; Salmanian AH; Mashayekhi F; Khodi S
    Tumour Biol; 2014 Nov; 35(11):11489-97. PubMed ID: 25128064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of the Tumor-Specific Antigen-Derived Synthetic Peptides as Potential Candidates for Targeting Breast and Other Possible Human Carcinomas.
    Okarvi SM; AlJammaz I
    Molecules; 2019 Aug; 24(17):. PubMed ID: 31470531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunogenicity Evaluation of Recombinant Edible Vaccine Candidate Containing HER2-MUC1 against Breast Cancer.
    Mehrab Mohseni M; Amani J; Fasihi Ramandi M; Mahjoubi F; Jafaria M; Salmanian AH
    Iran J Allergy Asthma Immunol; 2019 Oct; 18(5):511-522. PubMed ID: 32245295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of circulating anti-mucin 1 (MUC1) antibodies in breast tumor patients by indirect enzyme-linked immunosorbent assay using a recombinant MUC1 protein containing six tandem repeats and expressed in Escherichia coli.
    Tang Y; Wang L; Zhang P; Wei H; Gao R; Liu X; Yu Y; Wang L
    Clin Vaccine Immunol; 2010 Dec; 17(12):1903-8. PubMed ID: 20876819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Usefulness of Salivary and Serum Auto-antibodies Against Tumor Biomarkers HER2 and MUC1 in Breast Cancer Screening.
    Laidi F; Bouziane A; Errachid A; Zaoui F
    Asian Pac J Cancer Prev; 2016; 17(1):335-9. PubMed ID: 26838233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obtaining and characterization of monoclonal antibodies against recombinant extracellular domain of human epidermal growth factor receptor 2.
    Sarina N; Abeldenov S; Turgimbayeva A; Zhylkibayev A; Ramankulov Y; Khassenov B; Eskendirova S
    Hum Antibodies; 2018 Feb; 26(2):103-111. PubMed ID: 29036807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting the MUC1-C oncoprotein downregulates HER2 activation and abrogates trastuzumab resistance in breast cancer cells.
    Raina D; Uchida Y; Kharbanda A; Rajabi H; Panchamoorthy G; Jin C; Kharbanda S; Scaltriti M; Baselga J; Kufe D
    Oncogene; 2014 Jun; 33(26):3422-31. PubMed ID: 23912457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Mucin1 C-terminal Subunit-directed Monoclonal Antibody Targets Overexpressed Mucin1 in Breast Cancer.
    Wu G; Kim D; Kim JN; Park S; Maharjan S; Koh H; Moon K; Lee Y; Kwon HJ
    Theranostics; 2018; 8(1):78-91. PubMed ID: 29290794
    [No Abstract]   [Full Text] [Related]  

  • 9. Antibody response to HER2 extracellular domain and subdomains in mouse following DNA immunization.
    Sadri-Ardalani F; Shabani M; Amiri MM; Bahadori M; Emami S; Sarrafzadeh AR; Noutash-Haghighat F; Jeddi-Tehrani M; Shokri F
    Tumour Biol; 2016 Jan; 37(1):1217-27. PubMed ID: 26282003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Construction and evaluation of a novel humanized HER2-specific chimeric receptor.
    Sun M; Shi H; Liu C; Liu J; Liu X; Sun Y
    Breast Cancer Res; 2014 Jun; 16(3):R61. PubMed ID: 24919843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of tissue and serum HER2 and MUC1 in canine mammary cancer.
    Campos LC; Silva JO; Santos FS; Araújo MR; Lavalle GE; Ferreira E; Cassali GD
    J Vet Diagn Invest; 2015 Jul; 27(4):531-5. PubMed ID: 26179096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MUC1 isoform specific monoclonal antibody 6E6/2 detects preferential expression of the novel MUC1/Y protein in breast and ovarian cancer.
    Hartman M; Baruch A; Ron I; Aderet Y; Yoeli M; Sagi-Assif O; Greenstein S; Stadler Y; Weiss M; Harness E; Yaakubovits M; Keydar I; Smorodinsky NI; Wreschner DH
    Int J Cancer; 1999 Jul; 82(2):256-67. PubMed ID: 10389761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis, radiolabeling and in vitro and in vivo characterization of tumor-antigen- and antibody-derived peptides for the detection of breast cancer.
    Okarvi SM; Jammaz IA
    Anticancer Res; 2009 Apr; 29(4):1399-409. PubMed ID: 19414394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel chimeric DNA vaccine: enhancement of preventive and therapeutic efficacy of DNA vaccine by fusion of Mucin 1 to a heat shock protein 70 gene.
    Choi DH; Woo JK; Choi Y; Seo HS; Kim CW
    Mol Med Rep; 2011; 4(5):885-90. PubMed ID: 21725596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity of chimeric MUC1-HER2 vaccine against breast cancer in mice.
    Gheybi E; Salmanian AH; Fooladi AAI; Salimian J; Hosseini HM; Halabian R; Amani J
    Iran J Basic Med Sci; 2018 Jan; 21(1):26-32. PubMed ID: 29372033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting the MUC1-C oncoprotein inhibits self-renewal capacity of breast cancer cells.
    Alam M; Rajabi H; Ahmad R; Jin C; Kufe D
    Oncotarget; 2014 May; 5(9):2622-34. PubMed ID: 24770886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast cancer humoral immune response: involvement of Lewis y through the detection of circulating immune complexes and association with Mucin 1 (MUC1).
    Isla Larrain M; Demichelis S; Crespo M; Lacunza E; Barbera A; Cretón A; Terrier F; Segal-Eiras A; Croce MV
    J Exp Clin Cancer Res; 2009 Aug; 28(1):121. PubMed ID: 19715603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of a novel monoclonal antibody against tumor-associated MUC1 for diagnosis and prognosis of breast cancer.
    Stergiou N; Nagel J; Pektor S; Heimes AS; Jäkel J; Brenner W; Schmidt M; Miederer M; Kunz H; Roesch F; Schmitt E
    Int J Med Sci; 2019; 16(9):1188-1198. PubMed ID: 31588183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Changes in immune function of dendritic cells infected by recombinant adenovirus containing Her2/neu gene of extracellular and transmembrane domain proteins].
    Ma SD; Luo RC; Ding ZH; Lu F; Yuan CQ
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Aug; 26(8):1184-7. PubMed ID: 16939917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and Characterization of the Extracellular Domain of Human HER2 from Escherichia Coli, and Production of Polyclonal Antibodies Against the Recombinant Proteins.
    Sun Y; Feng X; Qu J; Han W; Liu Z; Li X; Zou M; Zhen Y; Zhu J
    Appl Biochem Biotechnol; 2015 Jun; 176(4):1029-43. PubMed ID: 25906688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.